Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology
Authors:
- C. PoulterCPC. Poulter
- H. KeysHKH. Keys
- P. RubinPRP. Rubin
- J. BeechamJBJ. Beecham
- K. DoaneKDK. Doane
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 14 (1) , 49-55
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastasesGynecologic Oncology, 1985
- Malignant Peritoneal Cytology as Prognostic Indicator in Stage I Endometrial CancerObstetrics & Gynecology, 1983
- Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticalsAmerican Journal of Obstetrics and Gynecology, 1981
- Surgery for endometrial cancerCancer, 1981
- The prognostic value of peritoneal cytology in gynecologic malignant diseaseAmerican Journal of Obstetrics and Gynecology, 1971